What We Do

GENOMIC ANALYTICS THAT ENABLES BETTER DRUG DEVELOPMENT, DISEASE DIAGNOSIS AND PATIENT TREATMENT

Oncology

Providing analytics that identify responders versus non-responders to immunotherapy treatment and predicting cancer progression

Cognitive Impairment

Early detection and better categorisation of Alzheimer's and Parkinsons disease to assist in delaying onset

Genomic Data Services

Optimising drug development and improving clinical trial design and outcomes

Point of Difference

How we do it

LEGAL

© 2020 GMDx Genomics. All rights reserved.